Abstract
Implant-associated infection is one of the most severe complications after total replacement of larger joints. The diagnosis of periprosthetic infection are often impeded as 5-34% of bacteriological tests are false-negative. Now the investigations of the immune status of patients suspected of periprosthetic infection are considered perspective as these are aimed at finding the most significant indicators for underlying the diagnosis of this pathology. In this research, we assessed immunology indicators in peripheral blood of patients with periprosthetic infection in their knee joints. We determined immunology characteristics associated with the clinical aspects of the progressing pathology. Our findings can be used as the basis for further search of pathophysiological mechanisms of periprosthetic infection progress in the knee joint as well as defining new diagnostic approaches.
Reviewers:
Ivanov A.N., MD, DSc;
Prof. Puchinyan D.M., MD, DSc
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was a part of the governmental assignment The development of medicines efficient against biofilm-forming microorganisms in treatment of infectious complications of articular replacement. Government reg. number 121032300172-2.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The research was approved by the Ethics Board of the Federal State Budgetary Educational Institution of Higher Education V.I. Razumovsky Saratov State Medical University, the Russian Federation Ministry of Healthcare
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Series editors Ulyanov V.Yu., MD, DSc, Assoc. Prof.; Grishin S.E., DSc – Saratov, NIITON SGMU. Publishing House Innovative Medical Technologies Ltd., 2021, 12 p. ISBN 978-5-6044610-4-4
e-mail: 10051968{at}mail.ru
e-mail: molop-sar{at}mail.ru
e-mail: v.u.ulyanov{at}gmail.com
Note: All authors give their permissions to post the full-text paper of this research to Irina A. Mamonova, PhD
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request
